535 related articles for article (PubMed ID: 27478953)
1. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
Espay AJ; LeWitt PA; Hauser RA; Merola A; Masellis M; Lang AE
Lancet Neurol; 2016 Aug; 15(9):954-966. PubMed ID: 27478953
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.
Shibao CA; Kaufmann H
CNS Drugs; 2017 Nov; 31(11):975-989. PubMed ID: 29076058
[TBL] [Abstract][Full Text] [Related]
3. Management of Orthostatic Hypotension in Parkinson's Disease.
Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of neurogenic orthostatic hypotension in long-term care facility residents with recurrent falls.
Shadmand M; Elliott B; Lautze J; Mehdirad A
Auton Neurosci; 2024 Feb; 251():103135. PubMed ID: 38065033
[TBL] [Abstract][Full Text] [Related]
6. [Orthostatic hypotension and supine hypertension in pure autonomic failure].
Sartori M; Pessina AC
Ital Heart J Suppl; 2004 Nov; 5(11):879-83. PubMed ID: 15633433
[TBL] [Abstract][Full Text] [Related]
7. Orthostatic hypotension in Parkinson's disease: Sit-to-stand vs. supine-to-stand protocol and clinical correlates.
Lim KB; Lim SY; Hor JW; Krishnan H; Mortadza F; Lim JL; Chinna K; Saedon NI; Tan AH
Parkinsonism Relat Disord; 2024 Jun; 123():106980. PubMed ID: 38657381
[TBL] [Abstract][Full Text] [Related]
8. [Orthostatic hypotension in patients with Parkinson's disease].
Zalyalova ZA; Khasanova DM; Ilina GR
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(6):16-21. PubMed ID: 37382973
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of orthostatic hypotension.
Wieling W; Kaufmann H; Claydon VE; van Wijnen VK; Harms MPM; Juraschek SP; Thijs RD
Lancet Neurol; 2022 Aug; 21(8):735-746. PubMed ID: 35841911
[TBL] [Abstract][Full Text] [Related]
10. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
Palma JA; Kaufmann H
Mov Disord; 2018 Mar; 33(3):372-390. PubMed ID: 29508455
[TBL] [Abstract][Full Text] [Related]
11. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
Isaacson SH; Skettini J
Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
[TBL] [Abstract][Full Text] [Related]
12. Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.
Baker J; Kimpinski K
CNS Drugs; 2017 Aug; 31(8):653-663. PubMed ID: 28702747
[TBL] [Abstract][Full Text] [Related]
13. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
Mobarek SK
BMC Cardiovasc Disord; 2020 Feb; 20(1):54. PubMed ID: 32019498
[TBL] [Abstract][Full Text] [Related]
14. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
McDonald C; Newton JL; Burn DJ
Mov Disord; 2016 Jul; 31(7):937-46. PubMed ID: 27091624
[TBL] [Abstract][Full Text] [Related]
15. Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.
Mehdirad A; Karabin B; Gupta F
Clin Auton Res; 2017 Jul; 27(Suppl 1):25-27. PubMed ID: 28634637
[No Abstract] [Full Text] [Related]
16. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management.
Pathak A; Senard JM
Expert Rev Neurother; 2006 Aug; 6(8):1173-80. PubMed ID: 16893345
[TBL] [Abstract][Full Text] [Related]
17. The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.
Palma JA; Redel-Traub G; Porciuncula A; Samaniego-Toro D; Millar Vernetti P; Lui YW; Norcliffe-Kaufmann L; Kaufmann H
Parkinsonism Relat Disord; 2020 Jun; 75():97-104. PubMed ID: 32516630
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?
Merola A; Romagnolo A; Rosso M; Lopez-Castellanos JR; Wissel BD; Larkin S; Bernardini A; Zibetti M; Maule S; Lopiano L; Espay AJ
Parkinsonism Relat Disord; 2016 Dec; 33():65-71. PubMed ID: 27641792
[TBL] [Abstract][Full Text] [Related]
19. Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
Cannom DS
J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1732-1734. PubMed ID: 31599484
[No Abstract] [Full Text] [Related]
20. Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.
Sforza M; Assogna F; Rinaldi D; Sette G; Tagliente S; Pontieri FE
Neurol Sci; 2018 Aug; 39(8):1459-1462. PubMed ID: 29627942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
